Treatment of Pancreatic Adenocarcinoma: A European Perspective

Surgical Oncology Clinics of North America

Volumn 17, Issue 3, 2008, Pages 569-586

  Gouma, Dirk J ^a   Busch, Olivier R C ^a   van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOSTATIN;

ADD ON THERAPY; ANALGESIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; HUMAN; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; QUALITY OF LIFE; REVIEW; STOMACH EMPTYING; TREATMENT DURATION; TUMOR BIOPSY;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; EUROPE; HORMONES; HUMANS; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROBIOTICS; RADIOTHERAPY, ADJUVANT; SOMATOSTATIN;

EID: 43449094334     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.02.005     Document Type: Review

References (131)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics 2002. CA Cancer J Clin 55 (2005) 74-108
2. Lowenfels A.B., and Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 197-209
3. Klein W.M., Hruban R.H., Klein-Szanto A.J., et al. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol 15 (2002) 441-447
4. Lochan R., Daly A.K., Reeves H.L., et al. Genetic susceptibility in pancreatic ductal adenocarcinoma. Br J Surg 95 (2008) 22-32
5. Ducreux M., Boige V., Goéré D., et al. Pancreatic cancer: from pathogenesis to cure. Best Pract Res Clin Gastroenterol 21 (2007) 997-1014
6. Vitone L.J., Greenhalf W., McFaul C.D., et al. The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol 20 (2006) 253-283
7. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 181 (1995) 483-503
8. Kuhlmann K.F., De Castro S.M., Wessling J.C., et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 40 (2004) 549-558
9. Trede M., Richter A., and Wendl K. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 81 (2001) 595-610
10. Tilleman E.H., Benraadt J., Bossuyt P.M., et al. Diagnosis and treatment of pancreatic carcinoma in the region of Amsterdam Comprehensive Cancer Care Center in 1997. Ned Tijdschr Geneeskd 145 (2001) 1358-1362 [in Dutch]
11. Michl P., Pauls S., and Gress T. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 227-251
12. Bipat S., Phoa S.S., Van Delden O.M., et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29 (2005) 438-445
13. Van Gulik T.M., Reeders J.W., Bosma A., et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 46 (1997) 417-423
14. Garrow D., Miller S., Sinha D., et al. Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol 5 (2007) 616-623
15. Hunt G.C., and Faigel D.O. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 55 (2002) 232-237
16. Zamboni G.A., Kruskal J.B., Vollmer C.M., et al. Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology 245 (2007) 770-778
17. Puli S.R., Singh S., Hagedorn C.H., et al. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest Endosc 65 (2007) 788-797
18. Pakzad F., Groves A.M., and Ell P.J. The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 36 (2006) 248-256
19. Bemelman W.A., De Wit L.D., Van Delden O.M., et al. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg 82 (1995) 820-824
20. Pisters P.W., Lee J.E., Vauthey J.N., et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg 88 (2001) 325-337
21. Nieveen van Dijkum E.J., de Wit L.T., van Delden O.M., et al. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma. J Am Coll Surg 189 (1999) 459-465
22. Nieveen van Dijkum E.J., Romijn M.G., Terwee C.B., et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237 (2003) 66-73
23. Tilleman E.H., Kuiken B.W., Phoa S.S., et al. Limitation of diagnostic laparoscopy for patients with a periampullary carcinoma. Eur J Surg 30 (2004) 658-662
24. Tilleman E.H., Busch O.R., Bemelman W.A., et al. Diagnostic laparoscopy in staging pancreatic carcinoma: developments during the past decade. J Hepatobiliary Pancreat Surg 11 (2004) 11-16
25. Whipple A.O., Parsons W.B., and Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 102 (1935) 763-779
26. Gouma D.J., Coelho J.C., Fisher J.D., et al. Endotoxemia after relief of biliary obstruction by internal and external drainage in rats. Am J Surg 151 (1986) 476-479
27. Gouma D.J., Coelho J.C., Schlegel J.F., et al. The effect of preoperative internal and external biliary drainage on mortality of jaundiced rats. Arch Surg 122 (1987) 731-734
28. Bemelmans M.H., Gouma D.J., Greve J.W., et al. Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br J Surg 80 (1993) 1055-1058
29. Kimmings A.N., van Deventer S.J., Obertop H., et al. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 46 (2000) 725-731
30. Kimmings N., Sewnath M.E., Mairuhu W.M., et al. The abnormal lipid spectrum in malignant obstructive jaundice in relation to endotoxin sensitivity and the result of preoperative biliary drainage. Surgery 129 (2001) 282-291
31. McPherson G.A., Benjamin I.S., Hodgson H.J., et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71 (1984) 371-375
32. Pitt H.A., Gomes A.S., Lois J.F., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg 201 (1985) 545-553
33. Hatfield A.R., Tobias R., Terblanche J., et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2 (1982) 896-899
34. Sewnath M.E., Birjmohun R.S., Rauws E.A., et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192 (2001) 726-734
35. Sohn T.A., Yeo C.J., Cameron J.L., et al. Do preoperative stents increase postpancreaticoduodenectomy complications. J Gastrointest Surg 4 (2000) 258-267
36. Povoski S.P., Karpeh Jr. M.S., Conlon K.C., et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230 (1999) 131-142
37. Sewnath M.E., Karsten T.M., Prins M.H., et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumours causing obstructive jaundice. Ann Surg 236 (2002) 17-27
38. Van der Gaag N.A., de Castro S.M., Rauws E.A., et al. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg 7 (2007) 3
39. Michalski C.W., Kleeff J., Bachmann J., et al. Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Ann Surg Oncol 15 (2008) 186-192
40. Siriwardana H.P., and Siriwardena A.K. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93 (2006) 662-673 [review]
41. Van Geenen R.C., Ten Kate F.J., De Wit L.T., et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129 (2001) 158-163
42. Phoa S.S., Tilleman E.H., Van Delden O.M., et al. Value of CT criteria in predicting survival in patients with potentially resectable pancreatic head carcinoma. J Surg Oncol 91 (2005) 33-40
43. Phoa S.S., Reeders J.W., Stoker J., et al. CT criteria for venous invasion in patients with pancreatic head carcinoma. Br J Radiol 73 (2000) 1159-1164
44. Shrikhande S.V., Kleeff J., Reiser C., et al. Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14 (2007) 118-127
45. Kleeff J., Reiser C., Hinz U., et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245 (2007) 566-572
46. Pedrazzoli S., Beger H., Obertop H., et al. A surgical and pathological based classification of resection of pancreatic cancer: summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 16 (1999) 337-345
47. Tran K.T., Smeenk H.G., Van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
48. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
49. Diener M.K., Knaebel H.P., Heukaufer C., et al. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245 (2007) 187-200
50. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228 (1998) 508-517
51. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-628 [discussion: 628-30]
52. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-622 [discussion: 622-4]
53. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366 [discussion: 366-8]
54. Nimura Y., Nagino M., Kato H., et al. Regional versus extended lymph node dissection in radical pancreaticoduodenectomy for pancreatic cancer: a multicenter, randomized controlled trial. HPB 6 (2004) 2
55. Michalski C.W., Kleeff J., Wente M.N., et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94 (2007) 265-273
56. Farnell M.B., Aranha G.V., Nimura Y., et al. The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 134 (2008) 706-715
57. Strasberg S.M., Drebin J.A., and Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery 133 (2003) 521-527
58. Shimada K., Sakamoto Y., Sano T., et al. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery 139 (2006) 288-295
59. Mabrut J.Y., Fernandez-Cruz L., Azagra J.S., et al. Hepatobiliary and Pancreatic Section (HBPS) of the Royal Belgian Society of Surgery; Belgian Group for Endoscopic Surgery (BGES); Club Coelio. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137 (2005) 597-605
60. Oussoultzoglou E., Bachellier P., Bigourdan J.M., et al. Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg 139 (2004) 327-335
61. Duffas J.P., Suc B., Msika S., et al. French Associations for Research in Surgery. A controlled randomized multicenter trial of pancreatogastrostomy or pancreatojejunostomy after pancreatoduodenectomy. Am J Surg 189 (2005) 720-729
62. Bassi C., Falconi M., Molinari E., et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 242 (2005) 767-771 [discussion: 771-3]
63. Wente M.N., Shrikhande S.V., Müller M.W., et al. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193 (2007) 171-183 [review]
64. McKay A., Mackenzie S., Sutherland F.R., et al. Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93 (2006) 929-936 [review]
65. Dixon E., Fingerhut A., Bassi C., et al. Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93 (2006) 1435 [authors' comment Br J Surg 2006; 93:929-36]
66. Peng S.Y., Wang J.W., Lau W.Y., et al. Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg 245 (2007) 692-698
67. Büchler M., Friess H., Klempa I., et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163 (1992) 125-130 [discussion: 130-1]
68. Pederzoli P., Bassi C., and Falconi M. et al, and the Italian Study Group. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 81 (1994) 265-269
69. Gouillat C., Chipponi J., Baulieux J., et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 88 (2001) 1456-1462
70. Suc B., Msika S., Piccinini M., et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective multicenter randomized controlled trial. Arch Surg 139 (2004) 288-294
71. Connor S., Alexakis N., Garden O.J., et al. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92 (2005) 1059-1067
72. Vanounou T., Pratt W.B., Callery M.P., et al. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg 205 (2007) 546-557
73. Rayes N., Seehofer D., Theruvath T., et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 246 (2007) 36-41
74. Van Santvoort H.C., Besselink M.G., Timmerman H.M., et al. Probiotics in surgery. Surgery 143 (2008) 1-7 [review]
75. Trede M., and Schwall G. The complications of pancreatectomy. Ann Surg 207 (1988) 39-47
76. Bassi C., Dervenis C., Butterini G., et al. Postoperative pancreatic fistula: an International Study Group on Pancreatic Fistula definition. Surgery 138 (2005) 8-13
77. Wente M.N., Veit J.A., Bassi C., et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142 (2007) 20-25
78. Wente M.N., Bassi C., Dervenis C., et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142 (2007) 761-768
79. Fernández-del Castillo C. Consensus defining postpancreatectomy complications: an opportunity we cannot ignore. Surgery 142 (2007) 771-772
80. Pratt W.B., Callery M.P., and Vollmer Jr. C.M. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg 32 (2008) 419-428
81. Strasberg S.M., Linehan D.C., Clavien P.A., et al. Proposal for definition and severity grading of pancreatic anastomosis failure and pancreatic occlusion failure. Surgery 141 (2007) 420-426
82. DeOliveira M.L., Winter J.M., Schafer M., et al. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244 (2006) 931-937 [discussion: 937-9]
83. Van Berge Henegouwen M.I., De Wit L.T., Van Gulik T.M., et al. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 185 (1997) 18-24
84. De Castro S.M., Busch O.R., Van Gulik T.M., et al. Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg 92 (2005) 1117-1123
85. Büchler M.W., Wagner M., Schmied B.M., et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003) 1310-1314 [discussion: 1315]
86. Muller M.W., Friess H., Kleeff J., et al. Is there still a role for total pancreatectomy. Ann Surg 246 (2007) 966-974 [discussion: 974-6]
87. De Castro S.M., Kuhlmann K.F., Busch O.R., et al. Delayed massive hemorrhage after pancreatic and biliary surgery: embolization or surgery?. Ann Surg 241 (2005) 85-91 [Comment in: Ann Surg 2006;243:138-9; author reply 139]
88. Heiss P., Bachthaler M., Hamer O.W., et al. Delayed visceral arterial hemorrhage following Whipple's procedure: minimally invasive treatment with covered stents. Ann Surg Oncol 15 (2008) 824-832
89. Yekebas E.F., Wolfram L., Cataldegirmen G., et al. Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg 246 (2007) 269-280
90. Lytras D., Paraskevas K.I., Avgerinos C., et al. Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection. Langenbecks Arch Surg 392 (2007) 1-12 [Epub Oct 5, 2006. Review]
91. Hartel M., Wente M.N., Hinz U., et al. Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 140 (2005) 1094-1099
92. Tani M., Terasawa H., Kawai M., et al. Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg 243 (2006) 316-320
93. Lieberman M.D., Kilburn H., Lindsey M., et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222 (1995) 638-645
94. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
95. Gouma D.J., De Wit L.T., Van Berge Henegouwen M.I., et al. Hospital experience and hospital mortality following partial pancreaticoduodenectomy in The Netherlands. Ned Tijdschr Geneeskd 141 (1997) 1738-1741 [in Dutch]
96. Gouma D.J., Van Geenen R.C., Van Gulik T.M., et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 232 (2000) 786-795
97. Nordback L., Parviainen M., Räty S., et al. Resection of the head of the pancreas in Finland: effects of hospital and surgeon on short-term and long-term results. Scand J Gastroenterol 37 (2002) 1454-1460
98. Roeder N., Wenke A., Heumann M., et al. Volume outcome relationship: consequences of reallocation of minimum volume based on current German surgical regulations. Chirurg 78 (2007) 1018-1027 [in German]
99. Topal B., Van de Sande S., Fieuws S., et al. Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay. Br J Surg 94 (2007) 1377-1381
100. Balzano G., Zerbi A., Capretti G., et al. Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg 95 (2008) 357-362
101. Van Heek N.T., Kuhlmann K.F., Scholten R.J., et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in The Netherlands. Ann Surg 242 (2005) 781-788 [discussion: 788-90]
102. Chowdhury M.M., Dagash H., and Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg 94 (2007) 145-161 [review]
103. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59 (1987) 2006-2010
104. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC GITCCG. Ann Surg 230 (1999) 776-784
105. Smeenk H.G., van Eijck C.H., Hop W.C., et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg 246 (2007) 734-740
106. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
107. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
108. Ghaneh P., Smith R., Tudor-Smith C., et al. Neoadjuvant and adjuvant strategies for pancreatic cancer. Eur J Surg Oncol 34 (2008) 297-305
109. Boeck S., Ankerst D.P., and Heinemann V. The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis. Oncology 72 (2008) 314-321
110. Nieveen van Dijkum E.J., Kuhlmann K.F., Terwee C.B., et al. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 92 (2005) 471-477
111. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340 (1992) 1488-1492
112. Bornmann P.C., Harries-Jones E.P., Tobias R., et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1 (1986) 69-71
113. Shepherd H.A., Royle G., Ross A.P., et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 75 (1988) 1166-1168
114. Andersen J.R., Sorensen S.M., Kruse A., et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 30 (1989) 1132-1135
115. Smith A.C., Dowsett J.F., Russell R.C., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344 (1994) 1655-1660
116. Müller M.W., Friess H., Köninger J., et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg 195 (2008) 221-228
117. Lillemoe K.D., Cameron J.L., Hardacre J.M., et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230 (1999) 322-328
118. vanHeek N.T., de Castro S.M., van Eijck C.H., et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238 (2003) 894-902
119. Telford J., carrlock D.L., Baron T.H., et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes of a multicenter study. Gastrointest Endosc 60 (2004) 916-920
120. Multignami N., Tringali A., Shah S.G., et al. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy 39 (2007) 440-447
121. Graber I., Dumas R., Filoche B., et al. The efficacy and safety of duodenal stenting: a prospective multicenter study. Endoscopy 39 (2007) 784-788
122. Wong G.Y., Schroeder D.R., Corns P.E., et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291 (2004) 1092-1099
123. Lillemoe K.D., Cameron J.L., Kaufman H.S., et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 217 (1993) 447-455
124. Michaels A., and Dragnov P.V. Endoscopic ultrasonography guided celiac plexus neurolysis. World J Gastroenterol 13 (2007) 3575-3580 [review]
125. Reinders M.E., Allema J.H., van Gulik T.M., et al. Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors. World J Surg 19 (1995) 410-414 [discussion: 414-5]
126. Lillemoe K.D., Cameron J.L., Yeo C.J., et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?. Ann Surg 223 (1996) 718-725
127. Kuhlmann K., de Castro S., van Heek T., et al. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery 139 (2006) 188-196
128. Ceha H.M., Van Tienhoven G., Gouma D.J., et al. Feasibility and efficacy of high dose conformal radiotherapy for locally advanced pancreatic cancer. Cancer 89 (2000) 2222-2229
129. De Lange S.M., Van Groeningen C.J., Meijer O.W., et al. Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer 38 (2002) 1212-1217
130. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
131. Bria E., Milella M., Gelibter A., et al. Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials. Cancer 110 (2007) 525-533